bepmed |

2098474
l 2002
WO

861. SCAFFOLD PRODUCT FOR HUMAN BONE TISSUE ENGINEERING, METHODS FOR ITS PREPARATION ANS USES THEREOF

Abstract

A scaffold product made of composite materials and uses thereof in the field of biomedical engineering are disclosed, wherein the composite materials comprise bioactive micro-particles...

13:59 / methods / Scaffolds

2444959
l 2002
CA

862. PROGENITOR CELL POPULATIONS, EXPANSION THEREOF, AND GROWTH OF NON-HEMATOPOIETIC CELL TYPES AND TISSUES THEREFROM

Abstract

Described is a method of expanding human progenitor cells by suspension culturing under non-static conditions. The culturing method provides a three - dimensional space for...

13:59 / cells / methods

2424062
l 2002
CA

863. PRIMITIVE NEURAL STEM CELLS AND METHOD FOR DIFFERENTIATION OF STEM CELLS TO NEURAL CELLS

Abstract

Described are a novel cell type in the neural lineage, and method of produci ng the same based on the degree of neural commitment and...

13:59 / cells / methods

2449978
l 2002
CA

864. BIOFUNCTIONAL FIBERS

Abstract

The present invention is directed to surface functionalization of polymeric fibers. Surface biofunctionalization is achieved by covalent conjugation of biofunctional igands and/or cell growth factors...

13:59 / methods / Scaffolds

2437417
l 2002
CA

865. THIOL-MODIFIED HYALURONAN

Abstract

The present invention relates to biscarbodiimides, thiourea derivatives, ure a derivatives, and cross-linked hyaluronan derivatives having at least one intramolecular disulfide bond, and methods of...

13:59 / methods / Scaffolds

2439612
l 2002
CA

866. MODULATION OF SMOOTH MUSCLE CELL PROLIFERATION BY VEGF-X OR ANTAGONISTS THEREOF

Abstract

There is provided a novel use for vascular endothelial growth factor, herein designated VEGF-X, and a CUB domain present in the sequence of VEGF-X, which...

13:59 / cells / methods

2444518
l 2002
CA

867. BIOMATERIALS COMPRISING A MELANOCYTE STIMULATING HORMONE (MSH), AND METHOD OF FORMING

Abstract

The present invention provides a vehicle for use in tissue engineering and/or surgical procedures comprising a Melanocyte Stimulating Hormone (MSH) recept or ligand: The vehicle...

13:59 / Biomaterial / methods

2438801
l 2002
CA

868. POROUS METALS AND METAL COATINGS FOR IMPLANTS

Abstract

The invention is directed to a method of preparing porous metals, as well as to these porous metals per se. More in particular the invention...

13:59 / Biomaterial / methods

2420901
l 2002
CA

869. SCAFFOLDS FOR TISSUE ENGINEERED HAIR

Abstract

Porous, bioabsorbable scaffolds for tissue engineering of human hair follicles, methods for their manufacture and methods of their use in creatin g new hair. Year: 2002 Country: ...

13:59 / methods / Scaffolds

2426819
l 2002
CA

870. TISSUE-ENGINEERED VASCULAR STRUCTURES

Abstract

The present invention is directed to novel, less invasive and improved metho ds of tissue-engineering of constructs that require an endothelial surface such as blood...

13:59 / methods / Scaffolds

Author: admin

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract